ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022 on the Updated OS Analysis for Docetaxel +/- Capivasertib in mCRPC: A Phase II ProCAID Trial Updates

29 views
February 24, 2022
Comments 0
Login to view comments. Click here to Login